CRISPR Activation Screens Reveal RNA-Based Mechanisms to Enhance Cancer Cell Sensitivity to T Cell Therapy
A study conducted at Stanford University has utilized high-content CRISPR activation screens to identify RNA-based mechanisms that can make cancer cells more susceptible to targeted T cell cytotoxicity. The research involved using CRISPR technology to activate specific genes in cancer cells, thereby sensitizing them to T cell attacks. The study focused on melanoma and breast adenocarcinoma cell lines, using engineered T cells to target cancer-specific antigens. The findings suggest that certain RNA pathways can be manipulated to enhance the effectiveness of T cell therapies, offering a potential new avenue for cancer treatment. 
